Health-related quality of life in prostate cancer patients in the Silesian Province (Poland) before and after radical prostatectomy – a longitudinal observational pilot study
More details
Hide details
Doctoral School, Faculty of Health Science, Medical University of Silesia, Katowice, Poland
Department of Rehabilitation, Faculty of Health Sciences, Medical University of Silesia, Katowice, Poland
Department of Urology and Urooncology, Medical Hospital, Gliwice, Poland
Tomasz Jurys   

Doctoral School, Faculty of Health Sciences in Katowice, Medical University of Silesia in Katowice, Poland
J Pre Clin Clin Res. 2022;16(3):94–98
Introduction and objective:
In recent years, patient-reported outcomes have played an increasingly important role in the evaluation of the effectiveness of treatments as aspects of health-related quality of life (e.g. physical, emotional, and psychosocial), and are taken into account in the selection of treatment methods and complementary management (e.g. nursing care or physiotherapy).

The aim of this pilot study was to assess changes in the health-related quality of life in a prostate cancer population before and 3 months after radical prostatectomy. The main motivation for the study is the small number of studies using validated tools to assess the quality of life of men in the Polish population suffering from prostate cancer.

Material and methods:
The study concerned 31 newly-diagnosed prostate cancer patients who qualified for radical prostatectomy. Quality of life assessment was performed twice – first before surgery, and then 3 months afterwards – using the EORTC QLQ-C30 and EORTC QLQ-PR25 questionnaires.

Comparison of baseline and 3-month follow-up results revealed significant deteriorations in patients’ quality of life across various domains, with the clinically and statistically most significant changes being observed on the emotional, social, and role functioning scales.

Radical prostatectomy contributed to decreased quality of life 3 months postoperatively. The psychosocial domains of the quality of life are more strongly affected than the physical domains.

Jurys T, Burzyński B, Kupilas A. Health-related quality of life in prostate cancer patients from the Silesian voivodeship (Poland) before and after radical prostatectomy: a longitudinal observational pilot study. J Pre-Clin Clin Res. 2022; 16(3): 94–98. doi: 10.26444/jpccr/153391
Ferlay J, Laversanne M, Ervik M, et al. Cancer Observatory: Cancer Tomorrow. Lyon, France: International Agency for Research on Cancer. Available online: https:// (accessed on 2022.05.03).
Kensler KH, Rebbeck TR. Cancer Progress and Priorities: Prostate Cancer. Cancer Epidemiol Biomarkers Prev. 2020; 29(2): 267–277. doi: 10.1158/1055–9965.EPI-19–0412.
Kimura T, Egawa S. Epidemiology of prostate cancer in Asian countries. Int J Urol. 2018; 25(6): 524–531. doi: 10.1111/iju.13593.
Didkowska J, Wojciechowska U, Olasek P, et al. Cancer in Poland in 2019. Available online: (accessed on 2022.05.03).
Carioli G, Bertuccio P, Boffetta P, et al. European cancer mortality predictions for the year 2020 with a focus on prostate cancer. Ann Oncol. 2020; 31(5): 650–658. doi: 10.1016/j.annonc.2020.02.009.
Mottet N, van den Bergh RCN, Briers E, et al. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol. 2021; 79(2); 243–262. doi: 10.1016/j.eururo.2020.09.042.
Jurys T, Dzierzawa M, Kwiecień A, et al. Physiotherapeutic treatment for urinary incontinence in men after radical prostatectomy. Med Og Nauk Zdr. 2019; 25(3): 144–148. doi:10.26444/monz/111668.
Cornford P, van den Bergh RCN, Briers E, et al. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II-2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer. Eur Urol. 2021; 79(2): 263–282. doi: 10.1016/j.eururo.2020.09.046.
Jurys T, Durmala J. Quality of life assessment using EORTC QLQ questionnaires in the prostate cancer population treated with radical prostatectomy: a systematic review. Scand J Urol. 2021; 55(2): 90–97. doi: 10.1080/21681805.2021.1871644.
Guan T, Santacroce SJ, Chen DG, et al. Illness uncertainty, coping, and quality of life among patients with prostate cancer. Psychooncology. 2020; 29(6): 1019–1025. doi: 10.1002/pon.5372.
Kao YL, Ou CH, Lin SH, et al.Dynamic Changes of Generic Quality of Life after Different Treatments for Localized Prostate Cancer. J Clin Med. 2021; 10(1): 158. doi: 10.3390/jcm10010158.
Shrestha A, Martin C, Burton M, et al. Quality of life versus length of life considerations in cancer patients: A systematic literature review. Psychooncology. 2019; 28(7): 1367–1380. doi: 10.1002/pon.5054.
Ratti MM, Gandaglia G, Alleva E, et al. Standardising the Assessment of Patient-reported Outcome Measures in Localised Prostate Cancer. A Systematic Review. Eur Urol Oncol. 2021; S2588–9311(21)00185–1. doi: 10.1016/j.euo.2021.10.004.
Jurys T, Smółka M, Dzierzawa-Kloza M, et al. EORTC QLQ-C30 and EORTC QLQ-PR25 — tools for assessing the quality of life of men suffering from prostate cancer. Oncol Clin Pract. 2022; 18(1): 61–67 doi: 10.5603/OCP.2021.0040.
King MT. The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30. Qual Life Res. 1996; 5(6): 555–567. doi: 10.1007/BF00439229.
Coens C, Pe M, Dueck AC, et al. Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints Data Consortium. International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium. Lancet Oncol. 2020; 21(2): e83-e96. doi: 10.1016/S1470–2045(19)30790–9.
Haraldstad K, Wahl A, Andenæs R, et al. A systematic review of quality of life research in medicine and health sciences. Qual Life Res. 2019; 28(10): 2641–2650. doi: 10.1007/s11136–019–02214–9.
Shin DW, Lee SH, Kim TH, et al. Health-Related Quality of Life Changes in Prostate Cancer Patients after Radical Prostatectomy: A Longitudinal Cohort Study. Cancer Res Treat. 2019; 51(2); 556–567. doi: 10.4143/crt.2018.221.
Holze S, Lemaire E, Mende M, et al. Quality of life after robotic-assisted and laparoscopic radical prostatectomy: Results of a multicenter randomized controlled trial (LAP-01). Prostate. 2022; 82(8): 894–903. doi: 10.1002/pros.24332.
Jurys T, Burzynski B, Potyka A, et al. Post-Radical Prostatectomy Erectile Dysfunction Assessed Using the IIEF-5 Questionnaire – A Systematic Literature Review. Int J Sex Health. 2022; 34(1): 55–64, doi: 10.1080/19317611.2021.1936333.
Baba N, Schrage T, Hartmann A, et al. Mental distress and need for psychosocial support in prostate cancer patients: An observational cross-sectional study. Int J Psychiatry Med. 2021; 56(1): 51–63. doi: 10.1177/0091217420938896.
Kollberg K, Thorsteinsdottir T, Wilderäng U, et al. Social constraints and psychological well-being after prostate cancer: A follow-up at 12 and 24 months after surgery. Psychooncology. 2018; 27(2): 668–675. doi: 10.1002/pon.4561.
Albisinni S, Aoun F, Quackels T, et al. Validated Prospective Assessment of Quality of Life After Robot-Assisted Laparoscopic Prostatectomy: Beyond Continence and Erections. Am J Mens Health. 2019; 13(3): 1557988319854555. doi: 10.1177/1557988319854555.